Accelerate drug discovery with AI: Nebius & NVIDIA BioNeMo

Drug discovery is often held back by expensive experiments, long training cycles and limited compute power.

In this webinar, you’ll see how NVIDIA BioNeMo, together with Nebius scalable cloud infrastructure, can reduce time and cost by accelerating model training, streamlining inference and powering complex computational biology workloads.

What you will learn

  • How NVIDIA’s BioNeMo accelerates AI model development and deployment in drug discovery.

  • Ways to deploy ready-to-use biology models — or build and adapt your own.

  • What the Nebius platform offers for scalable training, inference and HPC workloads.

  • Real-world use cases showing how biotech and pharma teams cut costs and speed up research with Nebius and NVIDIA.

Who should join

  • Biotech and pharma R&D teams accelerating drug discovery, bioinformatics or molecular modeling.

  • Researchers and startups adopting AI for new therapies or genomic studies.

  • Specialists needing scalable GPU/HPC for training, inference and custom models.

  • Organisations aiming to cut costs and speed up experiments vs. traditional methods.

  • Academic and enterprise groups seeking reliable, production-ready AI platforms.

Speakers

Ilya Burkov

Global Head of Life Science and Healthcare Growth at Nebius

Cedric Steenbeke

HCLS Startups Developer Relations Lead at NVIDIA

Arseniy Sokolov

Biotech AI Solutions Analyst at Nebius

Roy Tal Dew

Global DevRel for Biology at NVIDIA

Try Nebius AI Cloud console today

Get immediate access to NVIDIA® GPUs, along with CPU resources, storage and additional services through our user-friendly self-service console.